| Website | spiracur.com |
| Category | BioTech |
| Phone | 650 364 1544 |
| Employees | |
| Description | wound healing devices |
| Total | $55.3M |
| Series B, 6/09 Kleiner Perkins Caufield & Byers New Leaf Venture Partners De Novo Ventures | $20.3M |
| Unattributed, 2/11 Maverick Capital Pinnacle Ventures De Novo Ventures Kleiner Perkins Caufield & Byers New Leaf Venture Partners | $35M |
Spiracur Inc. is a privately held medical device company focused on the development of innovative wound healing technologies. Spiracur was founded out of the Stanford Biodesign Innovation Program in 2007. Its first product, the SNaP Wound Care System, grew out of the notion that current negative pressure wound therapies were too cumbersome for patients and clinicians. Spiracur strives to develop products that are truly patient-centric
